排序方式:
    總頁 1 
      Go

    1.Artesunate, a new antimalarial clinical drug, exhibits potent anti-AML activity by targeting the ROS/Bim and TFRC/Fe2+ pathways

    Liu, Y, Li, H, Luo,     More...

    BRITISH JOURNAL OF PHARMACOLOGY[0007-1188], Published 2023, Volume 180, Issue 6, Pages 701-720

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2022影響因子:  7.3 

    2.Ca2+ signalling plays a role in celastrol-mediated suppression of synovial fibroblasts of rheumatoid arthritis patients and experimental arthritis in rats

    Wong, VKW, Qiu, CL,     More...

    BRITISH JOURNAL OF PHARMACOLOGY[0007-1188], Published 2019, Volume 176, Issue 16, Pages 2922-2944

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 49  2022影響因子:  7.3  发表年影響因子:  7.730 

    顯示      條  合計   2   條
      總頁 1 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫